TEMPE, Ariz., March 24, 2016 /PRNewswire/ - ChiScan LLC and Trideum Biosciences LLC announce signing of a Memorandum of Understanding (MOU) for testing and development of a novel cold plasma technology. "We are very pleased to have entered into this agreement with ChiScan. This agreement continues to build on a working relationship between our teams," Van Sullivan, President and CEO Continue Reading